Solara Active Pharma Sciences Ltd. (SOLARA) Share Price Rises 8.49% Today

Solara Active Pharma Sciences Ltd. rose to Rs 596.6, up 8.49% today. The small-cap Healthcare stock has a market capitalisation of Rs 2,641.96 crore.

Solara Active Pharma Sciences Ltd. Share Price rose to Rs 596.6 on 20 August 2026, marking a same-day gain of Rs 46.7 or 8.49% from the previous close of Rs 549.9. With a market capitalisation of Rs 2,641.96 crore, the stock entered the session’s notable movers list as a Small Cap name in the Healthcare space. For readers tracking Solara Active Pharma Sciences Ltd. Share Price Today, the move stood out because the stock opened at Rs 549.3, touched an intraday high of Rs 603 and stayed above its day low of Rs 549.3 throughout the early trade window covered by the supplied data.

In today’s Solara Active Pharma Sciences Ltd. Stock News, the verified data confirms the price rise and strong intraday move, but it does not establish a company-specific catalyst behind the gain. That distinction matters. In Stock Market Today coverage, price action can be significant even when the available data only confirms the move, the turnover and the market-cap classification rather than a headline trigger.

From a broader market-analysis perspective, the stock’s valuation and profitability profile create an interesting contrast. Solara Active Pharma Sciences Ltd. Share Price is linked to a company showing a negative P/E ratio of -1754.71, yet a P/B ratio of 2.08, ROE of 17.23 and ROCE of 15.34. That mix helps explain why Solara Active Pharma Sciences Ltd. Share Price News is drawing attention on Univest, especially as investors compare the stock with other Pharmaceuticals & Drugs names and watch whether today’s rally is backed by sustained participation.

Solara Active Pharma Sciences Ltd. (SOLARA) Share Price Today: Price Action Analysis

Solara Active Pharma Sciences Ltd. (SOLARA) traded at Rs 596.6. versus the previous close of Rs 549.9, a rise of 8.49%. The stock opened at Rs 549.3, reached Rs 603, touched Rs 549.3. Reported volume was 20,556.

Solara Active Pharma Sciences Ltd. (SOLARA) Fundamental Analysis

Solara Active Pharma Sciences Ltd. was valued at a P/E ratio of -1,754.71x, a P/B ratio of 2.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 17.23% and ROCE of 15.34%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -0.34, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Solara Active Pharma Sciences Ltd. Fundamental Analysis shows a mixed but noteworthy setup. The company sits at a market capitalisation of Rs 2,641.96 crore with a P/B ratio of 2.08, ROE of 17.23 and ROCE of 15.34, while the reported P/E ratio is -1754.71 and EPS is -0.34.

Start with valuation. The negative P/E ratio of -1754.71 signals that the earnings base behind that multiple is currently not supportive in the conventional sense, and the EPS of -0.34 makes that clear. EPS measures the earnings attributable to each share, so a negative figure means the most recent earnings data used in this snapshot remains below zero. For Solara Active Pharma Sciences Ltd. Share Price, that creates an unusual combination because the stock is being valued by the market despite a negative earnings multiple.

Profitability numbers are stronger than the P/E suggests. ROE at 17.23 indicates the company has generated a double-digit return on shareholder equity, while ROCE at 15.34 reflects returns on capital employed that are also healthy in absolute terms. That means Solara Active Pharma Sciences Ltd. Stock Analysis cannot be reduced to the negative P/E alone. Market participants tracking Solara Active Pharma Sciences Ltd. Financial Results and Solara Active Pharma Sciences Ltd. Earnings are likely balancing the weak earnings-per-share snapshot against better return ratios.

Dividend yield is 0. That means the stock, based on the supplied data, is not offering a current historical payout yield relative to the present price. For investors reading Solara Active Pharma Sciences Ltd. Share News on Univest, the fundamental picture is therefore mixed: a small-cap pharma stock with a negative earnings multiple, no dividend yield, but return ratios that compare reasonably well within its industry. That naturally shifts attention toward sector context and peer positioning.

Sector and Industry Context

Solara Active Pharma Sciences Ltd. (SOLARA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of -1,754.71x, which is below the benchmark median of 24.91x, a difference of -7,144.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Solara Active Pharma Sciences Ltd. (SOLARA) has a ROE of 17.23%, which is above the benchmark median of 10.49%, a difference of +64.25%. Solara Active Pharma Sciences Ltd. (SOLARA) has a ROCE of 15.34%, which is above the benchmark median of 12.97%, a difference of +18.27%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Solara Active Pharma Sciences Ltd. Share Price is best read against the Healthcare sector and the Pharmaceuticals & Drugs industry. Within a same-industry benchmark of 136 companies, the company’s P/B, ROE and ROCE sit near or above important reference points, while its P/E remains an outlier because it is negative.

The supplied sectorSnapshot places the company in Healthcare and specifically in Pharmaceuticals & Drugs, with benchmarking based on the same industry across 136 companies. That is useful because it avoids overly broad sector comparisons. Within this benchmark scope, Solara’s company P/E is -1754.71. By contrast, among 105 companies with available P/E data, the median is 24.91, the average is 39.72, the minimum is 2.76 and the maximum is 357.74. On that basis, Solara Active Pharma Sciences Ltd. Share Price stands well outside the normal positive earnings-multiple range used for most peer valuation discussions.

The P/B comparison is more balanced. Solara’s company P/B is 2.08. Across 135 companies, the P/B median is 1.87, the average is 2.47, the minimum is -13.33 and the maximum is 16.47. That places the stock modestly above the median but below the average, suggesting neither the deepest discount nor the richest book-value premium in the peer set.

Profitability compares better. Solara’s company ROE is 17.23 versus an industry median of 10.49 and an average of 8.1 across 135 companies. Its company ROCE is 15.34 against a median of 12.97 and an average of 15.53 across 135 companies. So ROE is above both the median and average, while ROCE is above the median and marginally below the average. In market-cap terms, Solara is also much larger than the benchmark median. The same-industry market-cap median is Rs 140.77 crore, the average is Rs 491.98 crore, the minimum is Rs 5.94 crore and the maximum is Rs 3,012.78 crore across 136 companies. At Rs 2,641.96 crore, Solara Active Pharma Sciences Ltd. Market Cap sits near the upper end of that range, which helps explain why today’s price rise is drawing wider Market News attention on Univest.

Peer Comparison

Solara Active Pharma Sciences Ltd. (SOLARA) has a P/E ratio of -1,754.71x compared with the displayed peer median of 48.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.23% compares with a peer median of 0% across the companies shown in the table. ROCE stood at 15.34% versus the displayed peer median of 8.31%, providing a capital-efficiency comparison. Solara Active Pharma Sciences Ltd. (SOLARA) has a market capitalisation of Rs 2,641.96 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Peer data shows Solara Active Pharma Sciences Ltd. Share Price sits in a tightly clustered market-cap band with several listed Pharmaceuticals & Drugs companies. The stock does not screen cleanly on P/E because that figure is negative, but its P/B, ROE and ROCE are more comparable with peers.

Among the closest market-cap peers, Hikal Ltd. has a market cap of Rs 2,679.94 crore, very close to Solara’s Rs 2,641.96 crore. Hikal’s P/B is 2.22, slightly above Solara’s 2.08, while its ROE of 15.22 trails Solara’s 17.23 and its ROCE of 16.15 is modestly above Solara’s 15.34. Dishman Carbogen Amcis Ltd. stands at Rs 2,648.85 crore, almost identical in size, but its reported P/E is 167.12, P/B is 0.41, ROE is -2.89 and ROCE is -0.26. That comparison highlights how Solara’s return ratios are materially stronger than Dishman’s, even though Solara’s P/E is distorted by negative earnings.

Beta Drugs Ltd., with a market cap of Rs 2,610.72 crore, trades at a P/E of 64.32 and a much higher P/B of 10.17. Its ROE of 18.65 and ROCE of 22.17 are both above Solara’s figures, indicating stronger profitability but also a far richer book-value multiple. Panacea Biotec Ltd., at Rs 2,488.01 crore, has a P/B of 2.95, higher than Solara’s 2.08, but ROE of 0 and ROCE of 5.36, both well below Solara.

Further down the set, Venus Remedies Ltd. has a market cap of Rs 2,417.29 crore, P/E of 20.4, P/B of 3.45, ROE of 9.85 and ROCE of 7.89. Hester Biosciences Ltd., at Rs 2,073 crore, carries a P/E of 15.06 and P/B of 4.51, with ROE of 16.17 and ROCE of 14.12. Ind-Swift Laboratories Ltd., the largest name in the supplied cluster at Rs 3,012.78 crore, has a P/E of 48.9, P/B of 1.87, ROE of -0.78 and ROCE of 8.31. On balance, Solara Active Pharma Sciences Ltd. Stock Performance looks stronger than several similarly sized peers on ROE and ROCE, while its negative P/E keeps the valuation discussion more complex than a standard peer multiple comparison.

Why Investors Are Watching Solara Active Pharma Sciences Ltd.

Solara Active Pharma Sciences Ltd. Share Price is in focus because today’s move combined a visible price rise, a clean intraday gap from the previous close and a market-cap position near the upper end of its industry range. In Stocks in News and Top Gainers Today screens, that combination naturally attracts attention even when the supplied data does not identify a company-specific trigger.

• Price action: The stock rose Rs 46.7, or 8.49%, from Rs 549.9 to Rs 596.6 after opening at Rs 549.3 and touching Rs 603.
• Volume footprint: Total volume reached 4,52,871 shares, with 4,32,315 on NSE and 20,556 on BSE; turnover on the tracked exchange was Rs 1.23 crore.
• Fundamental context: P/E is -1754.71, P/B is 2.08, ROE is 17.23, ROCE is 15.34, EPS is -0.34 and dividend yield is 0.
• Sector positioning: In the same-industry benchmark, ROE is above both median and average, while P/B is above median but below average.
• Peer perspective: Market cap of Rs 2,641.96 crore places the company close to Hikal, Dishman Carbogen Amcis and Beta Drugs.

What investors may monitor next is whether Solara Active Pharma Sciences Ltd. Share Price continues to hold a meaningful part of today’s gain, how the stock trades relative to the Rs 603 intraday high, and whether future Solara Active Pharma Sciences Ltd. Latest News or earnings updates change the current mix of negative EPS and relatively solid return ratios. Univest readers often focus on that intersection of price action, profitability and peer valuation when a Small Cap healthcare stock becomes a top gainer.

About Solara Active Pharma Sciences Ltd.

Solara Active Pharma Sciences Ltd. operates in the Healthcare sector and is classified within the Pharmaceuticals & Drugs industry. Based on the supplied data, that places the company in one of the largest listed industry sets in the market snapshot used here, with 136 same-industry companies forming the benchmark universe.

Even without a longer business description in the supplied dataset, the classification itself offers useful context for Solara Active Pharma Sciences Ltd. Company News. Pharmaceuticals & Drugs companies are typically evaluated on a mix of earnings, capital efficiency, valuation and market size, and Solara’s current market profile fits squarely into that framework. Its market capitalisation of Rs 2,641.96 crore is far above the industry median of Rs 140.77 crore and also above the benchmark average of Rs 491.98 crore, placing it among the larger companies in its same-industry comparison set.

That scale matters because Solara Active Pharma Sciences Ltd. Share Price does not move in isolation from industry standards. Investors comparing the company with peers such as Hikal, Dishman Carbogen Amcis, Beta Drugs, Panacea Biotec and Venus Remedies are effectively comparing size, valuation and return ratios within the same listed Pharmaceuticals & Drugs space. For readers using Univest for Solara Active Pharma Sciences Ltd. NSE and Solara Active Pharma Sciences Ltd. BSE tracking, the company’s industry placement is therefore central to understanding both today’s market move and the broader stock analysis around it.

Track Solara Active Pharma Sciences Ltd. Share Price on Univest

Use Solara Active Pharma Sciences Ltd. (SOLARA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors following Solara Active Pharma Sciences Ltd. Share Price can use Univest to track live price updates, daily change, market capitalisation, valuation ratios and broader market context in one place. Solara Active Pharma Sciences Ltd. Share Price Today, along with 52-week levels, shareholding pattern updates when available, peer comparisons, sector benchmarks and key profitability metrics, can be monitored through Univest’s stock research interface.

For users who track Stocks Rising Today and Market Movers, Univest also helps connect intraday price action with deeper Fundamental Analysis and industry-relative Stock Performance. That can be especially useful in sessions like this one, when Solara Active Pharma Sciences Ltd. Share Price News is driven by verified market data and price movement rather than a disclosed company-specific catalyst in the supplied snapshot.

Frequently Asked Questions

What is Solara Active Pharma Sciences Ltd. Share Price today?

Ans. Solara Active Pharma Sciences Ltd. Share Price was Rs 596.6 at the time covered by the supplied data. The stock was up Rs 46.7, or 8.49%, from the previous close of Rs 549.9.

Why is Solara Active Pharma Sciences Ltd. rising today?

Ans. The supplied data confirms that Solara Active Pharma Sciences Ltd. rose 8.49% in the session and qualified as a notable Small Cap price rise. However, the dataset confirms the move itself rather than a company-specific catalyst.

What were the day high and day low for Solara Active Pharma Sciences Ltd.?

Ans. Solara Active Pharma Sciences Ltd. traded between Rs 549.3 and Rs 603 in the session covered here. It opened at Rs 549.3, which was also the day low, before moving sharply higher intraday.

How much volume was traded in Solara Active Pharma Sciences Ltd. today?

Ans. Total traded volume stood at 4,52,871 shares in the supplied snapshot. Of this, NSE accounted for 4,32,315 shares, while BSE volume was 20,556 shares, showing that most participation came from NSE.

What is the market capitalisation of Solara Active Pharma Sciences Ltd.?

Ans. Solara Active Pharma Sciences Ltd. had a market capitalisation of Rs 2,641.96 crore in the supplied data. That places it in the Small Cap category and near the upper end of its same-industry benchmark range.

Is Solara Active Pharma Sciences Ltd. expensive compared with its industry on P/B?

Ans. On P/B, Solara Active Pharma Sciences Ltd. was at 2.08. That is above the same-industry median of 1.87 but below the average of 2.47, suggesting a mid-range valuation on this specific metric.

How do Solara Active Pharma Sciences Ltd. profitability ratios compare with the industry?

Ans. Solara reported ROE of 17.23 and ROCE of 15.34. Against the same-industry benchmark, ROE is above the median of 10.49 and average of 8.1, while ROCE is above the median of 12.97.

What does the negative P/E ratio of Solara Active Pharma Sciences Ltd. indicate?

Ans. Solara Active Pharma Sciences Ltd. had a P/E ratio of -1754.71 and EPS of -0.34 in the supplied data. That means the conventional earnings multiple is negative, making book value and return ratios more relevant context.

Does Solara Active Pharma Sciences Ltd. pay a dividend yield right now?

Ans. The supplied snapshot shows a dividend yield of 0 for Solara Active Pharma Sciences Ltd. This means the current historical payout yield, relative to the prevailing share price, is not contributing to the stock’s valuation profile.

Which peer stocks are closest to Solara Active Pharma Sciences Ltd. by market cap?

Ans. The closest supplied peers by market capitalisation are Hikal at Rs 2,679.94 crore, Dishman Carbogen Amcis at Rs 2,648.85 crore and Beta Drugs at Rs 2,610.72 crore, all near Solara’s Rs 2,641.96 crore.